TY  - JOUR
AU  - Kinner, SA
AU  - Snow, K
AU  - Wirtz, AL
AU  - Altice, FL
AU  - Beyrer, C
AU  - Dolan, K
Y2  - 2020/12/09
Y1  - 2018/03/01
SN  - 1054-139X
UR  - http://hdl.handle.net/11343/253203
AB  - PURPOSE: This study aims to compare the global prevalence of hepatitis B, hepatitis C, HIV, and tuberculosis in incarcerated adolescents and young adults (AYAs) and older prisoners. METHODS: This study is a systematic review and meta-analysis of studies reporting the age-specific prevalence of each infection in prisoners. We grouped age-specific prevalence estimates into three overlapping age categories: AYA prisoners (<25 years), older prisoners (≥25 years), and mixed category (spanning age 25 years). We used random effects meta-analysis to estimate the relative risk (RR) of each infection in AYAs versus older prisoners. RESULTS: Among 72 studies, there was marked heterogeneity in prevalence estimates among AYA prisoners for all infections: hepatitis B (.4%-25.2%), hepatitis C (.0%-70.6%), HIV (.0%-15.8%), and active tuberculosis (.0%-3.7%). The pooled prevalence of HIV (RR = .39, 95% confidence interval .29-.53, I2 = 79.2%) and hepatitis C (RR = .51, 95% confidence interval .33-.78, I2 = 97.8%) was lower in AYAs than in older prisoners. CONCLUSIONS: The prevalence of HIV and hepatitis C is lower in AYA prisoners than in older prisoners. Despite lower prevalence, acquisition begins early among incarcerated populations. There is an urgent need for targeted, age-appropriate prevention, treatment, and harm reduction measures in and beyond custodial settings to reduce the incidence of infection in these extremely vulnerable young people.
LA  - English
PB  - ELSEVIER SCIENCE INC
T1  - Age-Specific Global Prevalence of Hepatitis B, Hepatitis C, HIV, and Tuberculosis Among Incarcerated People: A Systematic Review
DO  - 10.1016/j.jadohealth.2017.09.030
IS  - Journal of Adolescent Health
VL  - 62
IS  - 3
SP  - S18-S26
OP  - 1078168
L1  - /bitstream/handle/11343/253203/PMC7413042.pdf?sequence=1&isAllowed=y
ER  -